LYRA THERAPEUTICS INC
Q2 2025 13F Holders
Symbol
LYRA
CUSIP
55234L204
Type
Equity
Class
COM NEW
Num filings
32
Total reported value, excl. options
$4.43 M
Compare 2025 Q2 to
2026 Q1
2025 Q4
2025 Q3
Manager
Report Date
Value ($000)
Shares
Option Type